Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time-Reference-Cited by-同舟云学术

Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time

Published:2017-09-05 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Chia Shumei,Low Joo-Leng,Zhang Xiaoqian,Kwang Xue-Lin,Chong Fui-Teen,Sharma Ankur,Bertrand Denis,Toh Shen Yon,Leong Hui-Sun,Thangavelu Matan T.,Hwang Jacqueline S. G.,Lim Kok-Hing,Skanthakumar Thakshayeni^ORCID,Tan Hiang-Khoon,Su Yan,Hui Choo Siang,Hentze Hannes,Tan Iain B. H.,Lezhava Alexander,Tan Patrick,Tan Daniel S. W.,Periyasamy Giridharan,Koh Judice L. Y.,Gopalakrishna Iyer N.,DasGupta Ramanuj

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-00451-5.pdf

Reference47 articles.

1. Meric-Bernstam, F. et al. A decision support framework for genomically informed investigational cancer therapy. J. Natl Cancer Inst. 107, djv098 (2015).

2. Garraway, L. A. Genomics-driven oncology: framework for an emerging paradigm. J. Clin. Oncol. 31, 1806–1814 (2013).

3. Uzilov, A. V. et al. Development and clinical application of an integrative genomic approach to personalized cancer therapy. Genome Med. 8, 62 (2016).

4. Jones, S. et al. Personalized genomic analyses for cancer mutation discovery and interpretation. Sci. Transl. Med. 7, 283ra253 (2015).

5. Xue, Y. & Wilcox, W. R. Changing paradigm of cancer therapy: precision medicine by next-generation sequencing. Cancer Biol. Med. 13, 12–18 (2016).

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors;Developmental Cell;2024-08

2. Heterogeneity, Bayesian thinking, and phenotyping in critical care: A primer;American Journal of Health-System Pharmacy;2024-05-14

3. An AI‐assisted integrated, scalable, single‐cell phenomic‐transcriptomic platform to elucidate intratumor heterogeneity against immune response;Bioengineering & Translational Medicine;2024-01-02

4. Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome change;2023-12-13

5. Predicting drug response from single-cell expression profiles of tumours;BMC Medicine;2023-12-01